Dept of Pathology, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA.
Am J Clin Pathol. 2010 May;133(5):762-6. doi: 10.1309/AJCPIPU1MPTBM2FQ.
We immunohistochemically studied TCL1 protein expression in different histologic types of 63 testicular germ cell tumors: 23 seminomas, 14 embryonal carcinomas, 4 teratomas, 2 yolk sac tumors, and 20 mixed germ cell tumors. The 20 mixed germ cell tumors contained components of seminoma (n = 10), embryonal carcinoma (n = 18), teratoma (n = 16), yolk sac tumor (n = 7), and choriocarcinoma (n = 3). We also examined 40 cases of intratubular germ cell neoplasia, unclassified type (IGCNU). Positive immunoreactivity for TCL1 was observed in 91% of the seminoma samples (30/33) and all IGCNU cases. In contrast, no TCL1 expression was detected among the nonseminomatous germ cell tumors. In the context of testicular germ cell neoplasia, the presence of TCL1 protein appears restricted to IGCNU and seminoma, suggesting association with an undifferentiated state and loss of protein expression with tumor differentiation. Immunohistochemical evaluation of TCL1 expression may have usefulness in substantiating a diagnosis of IGCNU or seminoma and in the separation of seminoma from nonseminomatous germ cell tumors.
我们免疫组化研究了 TCL1 蛋白在 63 例不同组织学类型睾丸生殖细胞肿瘤中的表达:23 例精原细胞瘤、14 例胚胎癌、4 例畸胎瘤、2 例卵黄囊瘤和 20 例混合性生殖细胞肿瘤。20 例混合性生殖细胞肿瘤包含精原细胞瘤成分(n = 10)、胚胎癌成分(n = 18)、畸胎瘤成分(n = 16)、卵黄囊瘤成分(n = 7)和绒毛膜癌成分(n = 3)。我们还检查了 40 例未分类型小管内生殖细胞肿瘤(IGCNU)。30/33 例精原细胞瘤样本和所有 IGCNU 病例均对 TCL1 呈阳性免疫反应。相比之下,非精原细胞瘤生殖细胞肿瘤中未检测到 TCL1 表达。在睾丸生殖细胞肿瘤中,TCL1 蛋白的存在似乎仅限于 IGCNU 和精原细胞瘤,提示与未分化状态相关,且随着肿瘤分化,蛋白表达丢失。TCL1 表达的免疫组化评估可能有助于证实 IGCNU 或精原细胞瘤的诊断,并有助于将精原细胞瘤与非精原细胞瘤生殖细胞肿瘤分开。